News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Myeloma Paper of the Day, July 15th, Suggested by Robert Orlowski
Jul 15, 2025, 09:21

Myeloma Paper of the Day, July 15th, Suggested by Robert Orlowski

Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day:

Interleukin-6 is a prognostic biomarker for POEMS syndrome associated with EFS and OS (patients with elevated IL-6 had 17-fold increased risk of death vs. those with normal values), along with hypoalbuminemia and a high Wang score.”

Title: Interleukin-6 is a highly prognostic biomarker for POEMS syndrome

Authors: Joselle Cook, Rahma Warsame, Maryam Omar, Francis K. Buadi, Nadine Abdallah, David Dingli, Suzanne R. Hayman, Prashant Kapoor, Taxiarchis Kourelis, Moritz Binder, Eli Muchtar, Amie Fonder, Yi L. Hwa, Miriam A. Hobbs, Yi Lin, Wilson I. Gonsalves, Morie A. Gertz, Shaji K. Kumar, S. Vincent Rajkumar, Angela Dispenzieri

You can read the Full Article in Leukemia.

Myeloma Paper of the Day, July 15th, Suggested by Robert Orlowski

You can find more posts featuring Robert Orlowski in OncoDaily.

Amie Fonder Angela Dispenzieri cancer David Dingli Eli Muchtar Francis K. Buadi Interleukin-6 Joselle Cook Leukemia Maryam Omar Miriam A Hobbs Morie A Gertz Moritz Binder Myeloma Myeloma Paper of the Day Nadine Abdallah OncoDaily Oncology POEMS syndrome Prashant Kapoor Rahma Warsame Robert Orlowski S Vincent Rajkumar Shaji K. Kumar Suzanne R Hayman Taxiarchis Kourelis Wilson I. Gonsalves Yi L. Hwa Yi Lin
Special Coverage
Voices
Aug 25, 2025, 19:00
Jarushka Naidoo: Irish Oncology in Full Force at the ESMO Academy 2025
Voices
Aug 25, 2025, 18:30
Shadha S. Al-Raisi: The Latest Cancer Incidence Report in Oman Has Been Released
Insight
Aug 25, 2025, 17:47
Alexey Kulikov: Key Findings from the Recent Meta-Analysis on Daily Steps and Health Outcomes
Voices
Aug 25, 2025, 17:36
Lauren Kriger Groner: Learning to Make White Ribbons from the Very Best
Science
Aug 25, 2025, 17:28
Galip Can Uyar: How GA-Guided Care Improves Coping in Older Adults with Metastatic Cancer
Science
Aug 25, 2025, 17:18
Giuseppe Banna: Deferred Nephrectomy after ICI in RCC May Enable Treatment De-Escalation
Science
Aug 25, 2025, 17:08
Moazzam Shahzad: Upfront Immunotherapy Approaches in the Management of Adults with ALL
Science
Aug 25, 2025, 17:00
Chris Poulios: Pathologist-Read vs AI-Driven Assessment of Tumor-Infiltrating Lymphocytes in Melanoma
Voices
Aug 25, 2025, 16:44
Martin Zapata Laguado: Honored to Speak on mRCC First-Line Therapy and dCN in the IO Era
Voices
Aug 25, 2025, 16:30
Sarcoma 101 at Fellowship Bootcamp with Steve Bialick - Miami Hematology Oncology Program Director
Science
Aug 25, 2025, 16:04
George Kumar Shares Breakthrough in Cold Plasma Oncology
Voices
Aug 25, 2025, 15:59
Cancer Research Institute Highlights Its Role in Immune-Based Cancer Breakthroughs